IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q2 2014 Holdings

Filed 2014-08-08 | 16 holdings | $346.0K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2014-09-12) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Versartis IncACOM92529L102$55.9K1,994,56816.2%
Transenterix IncCOM NEW89366M201$42.0K8,335,81912.1%
Zeltiq Aesthetics IncCOM98933Q108$39.5K2,597,74211.4%
Cempra IncCOM15130J109$35.3K3,293,06010.2%
Durata Therapeutics IncCOM26658A107$34.6K2,030,17510.0%
Chimerix Inc(CMRXEUR)COM16934W106$33.4K1,522,9439.7%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$32.5K2,054,5949.4%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$18.9K2,171,8315.5%
Pernix Therapeutics Hldgs inCOM71426V108$18.1K2,010,0005.2%
Sorrento Therapeutics Inc(SRNE)COM NEW83587F202$11.9K1,763,5003.4%
Ambit Biosciences CorpCOM02318X100$11.4K1,650,1563.3%
Lombard MED IncCOMG55598109$6.4K886,3631.8%
MEI Pharma IncCOM NEW55279B202$4.9K770,0001.4%
Zeltiq Aesthetics IncCallCOM98933Q108$65743,2610.2%
Cempra IncCallCOM15130J109$42940,0000.1%
Pernix Therapeutics Hldgs inCallCOM71426V108$9010,0000.0%